Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro
Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders
Cannabidiol/tacrolimus
Cannabidiol/naloxone
Cannabidiol/nabiximols
Cannabidiol (CBD)